BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, December 5, 2025
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 1, 2011
View Archived Issues
iBioLaunch platform expresses protein to be studied as vaccine against hookworm disease
Read More
NicOx's NCX-226 reduces symptoms of inflammation in murine model of lung fibrosis
Read More
Olanzapine oral and LAI formulations show similar effectiveness in schizophrenia
Read More
R1-1084 and R1-770 well tolerated by patients with metastatic renal cell carcinoma
Read More
RLY-5016 dose titration avoids hypokalemia in patients with heart failure and kidney disease
Read More
Intedanib has beneficial effects in TOMORROW trial in idiopathic pulmonary fibrosis
Read More
Scientists at GSK design new P2X7 receptor antagonists
Read More
Novel cyclic dipeptides for neurodegenerative diseases presented
Read More
New diacylglycerol O-acyltransferase 1 inhibitors patented
Read More
GSK claims new inhibitors of serine/threonine-protein kinase TNNI3K
Read More
Novel bromodomain-containing protein inhibitors disclosed
Read More
InterMune reports new NS5B inhibitors for hepatitis C
Read More
Nationwide Children's Hospital receives NIH grant to advance gene therapy for MPS IIIB
Read More
Initiation of phase I trial in pain triggers milestone payment to Evotec from Boehringer Ingelheim
Read More
First patient enrolled in high-dose cohort of phase II SHIGATEC trial
Read More
European Commission approves extended use of Carbaglu for organic acidemias
Read More
Dyax and Defiante Farmaceutica expand agreement for ecallantide in HAE
Read More
Cleveland BioLabs and BARDA advance negotiations relating to development of CBLB-502
Read More
Affymax and Takeda submit NDA for peginesatide in anemia associated with chronic renal failure
Read More
GenKyoTex raises funds to develop NADPH oxidase inhibitors
Read More
Nuron Biotech to use PolyTherics' TheraPEG technology for long-acting MS therapy
Read More
BioSante completes enrollment in phase III safety study of LibiGel
Read More
Capstone Therapeutics and BiolineRx sign agreement for development of Chrysalin in AMI
Read More
Diamyd Medical stops follow-up in European phase III study of Diamyd in diabetes
Read More